MALLINCKRODT UK FINANCE LLP

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

U.S. Study of Fibrocaps in Surgical Hemostasis

First Posted Date
2010-12-08
Last Posted Date
2017-09-13
Lead Sponsor
Mallinckrodt
Target Recruit Count
70
Registration Number
NCT01256164
Locations
🇺🇸

Various sites, Indianapolis, Indiana, United States

Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel

First Posted Date
2010-09-16
Last Posted Date
2014-09-23
Lead Sponsor
Mallinckrodt
Target Recruit Count
30
Registration Number
NCT01202799
Locations
🇺🇸

Comprehensive Phase One, Miramar, Florida, United States

Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.

First Posted Date
2010-08-02
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Target Recruit Count
50
Registration Number
NCT01173627
Locations
🇺🇸

PRACS Institute, Ltd, Fargo, North Dakota, United States

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-06-14
Last Posted Date
2022-11-29
Lead Sponsor
Mallinckrodt
Target Recruit Count
196
Registration Number
NCT01143246
Locations
🇺🇸

Scripps Clinic, La Jolla, California, United States

🇺🇸

University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States

🇺🇸

Iowa City VA Health Care System, Iowa City, Iowa, United States

and more 70 locations

Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-05-10
Last Posted Date
2019-10-22
Lead Sponsor
Mallinckrodt
Target Recruit Count
260
Registration Number
NCT01119898
Locations
🇺🇸

Clinical Trials Technology, Inc., Prairie Village, Kansas, United States

🇺🇸

Crescent Medical Research, Salisbury, North Carolina, United States

🇺🇸

Palmetto Medical Research, Mount Pleasant, South Carolina, United States

and more 18 locations

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2009-07-23
Last Posted Date
2016-09-09
Lead Sponsor
Mallinckrodt
Target Recruit Count
150
Registration Number
NCT00944372
Locations
🇺🇸

University of Miami, Jackson Memorial Hospital, Miami, Florida, United States

🇺🇸

University of Iowa Medical Center, Iowa City, Iowa, United States

🇺🇸

Louisiana State University, Division of Hem/Onc, New Orleans, Louisiana, United States

and more 1 locations

Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants

First Posted Date
2009-07-02
Last Posted Date
2017-12-04
Lead Sponsor
Mallinckrodt
Target Recruit Count
451
Registration Number
NCT00931632
Locations
🇺🇸

Saint Francis Children's Hospital, Tulsa, Oklahoma, United States

🇺🇸

Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States

🇺🇸

Winnie Palmer Hospital for Women and Babies, Orlando, Florida, United States

and more 30 locations

Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure

First Posted Date
2009-06-17
Last Posted Date
2016-09-09
Lead Sponsor
Mallinckrodt
Registration Number
NCT00922532

Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2009-04-10
Last Posted Date
2019-12-17
Lead Sponsor
Mallinckrodt
Target Recruit Count
28
Registration Number
NCT00879645
Locations
🇺🇸

DaVita Clinical Research, Minneapolis, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath